Actavis Agrees US$8.5 B Buyout of Warner Chilcott to Expand Speciality Drug Portfolio
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 5 (Table of Contents)
Published: 29 May-2013
DOI: 10.3833/pdr.v2013.i5.1944 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to expand its speciality branded drug portfolio, Actavis has agreed to buy Warner Chilcott for approximately US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS